Literature DB >> 6151923

Langerhans cells in human papillomavirus (HPV) lesions of the uterine cervix identified by the monoclonal antibody OKT-6.

M Väyrynen, K Syrjänen, R Mäntyjärvi, O Castrén, S Saarikoski.   

Abstract

The local inflammatory cell infiltrates in 263 cervical punch biopsies of the women followed-up since 1981 (16 +/- 14 months, mean +/- S.D.) for an established human papillomavirus (HPV) lesion with or without concomitant cervical intraepithelial neoplasia (CIN) were analysed for occurrence of Langerhans cells, defined by the monoclonal antibody OKT-6 using the avidin-biotin peroxidase complex (ABC) technique. OKT-6+ cells remained at the constant low level (1.5-1.9% of the inflammatory cells) in the different types of HPV lesions (flat, inverted or papillomatous condylomas), their percentages (range 0.8-2.1% of the cells) being slightly affected by the grade of HPV-associated CIN, however, (P less than 0.05 between HPV-CIN I and HPV-CIS). Although cervical HPV lesions characteristically are a disease of young females, the relative levels of in situ Langerhans cells did not show any age-dependence. Furthermore, the intensity of the inflammatory cell infiltrate did not correlate with the relative levels of OKT-6+ cells in the biopsies. Practically identical (1.6%) levels of OKT-6+ cells were found in the first biopsies of the HPV lesions shown to regress during the follow-up period (28.8% of cases), when compared with those (1.7%) in the lesions persisted (52.1% of cases) or progressed (19.1% of lesions). The results are discussed in terms of the proposed immune surveillance function against viral infections, attributed to Langerhans cells in the SALT/MALT concept.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151923     DOI: 10.1016/0020-7292(84)90070-5

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  6 in total

1.  Density and distribution of Langerhans cells in the human uterine cervix.

Authors:  A E Morelli; G di Paola; L Fainboim
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

Review 2.  Distribution of epithelial antigens in the human uterine cervix: a review.

Authors:  V Serra; A Ramirez; M C Marzo; F Valcuende; C Lara; A Castells; F Bonilla-Musoles
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract.

Authors:  Rafael Jimenez-Flores; Rene Mendez-Cruz; Jorge Ojeda-Ortiz; Rebeca Muñoz-Molina; Oscar Balderas-Carrillo; Maria de la Luz Diaz-Soberanes; Serge Lebecque; Sem Saeland; Adrian Daneri-Navarro; Alejandro Garcia-Carranca; Stephen E Ullrich; Leopoldo Flores-Romo
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

Review 4.  Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer.

Authors:  B Clarke; R Chetty
Journal:  Mol Pathol       Date:  2002-02

5.  Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.

Authors:  Stina Syrjänen; Paulo Naud; Luis Sarian; Sophie Derchain; Cecilia Roteli-Martins; Adhemar Longatto-Filho; Silvio Tatti; Margherita Branca; Mojca Erzen; L S Hammes; S Costa; Kari Syrjänen
Journal:  Virchows Arch       Date:  2009-11-12       Impact factor: 4.064

6.  Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix.

Authors:  W al-Saleh; P Delvenne; J E Arrese; A F Nikkels; G E Piérard; J Boniver
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.